España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
UroGen Pharma
URGN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$11.04
0.00
0.00%
Pre-Market: 4:00 PM EDT
Get Report
Comment
UroGen Pharma (URGN) Forecast
News
Earnings
UroGen Pharma (URGN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for UroGen Pharma (NASDAQ:URGN) Stock
UroGen Pharma Stock (NASDAQ: URGN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, December 06, 2024
D. Boral Capital Maintains Buy on UroGen Phar...
Benzinga Newsdesk
Thursday, December 05, 2024
UroGen Pharma Highlights Results From A Long-...
Benzinga Newsdesk
UroGen Pharma Announces UGN-102 Long-Term Res...
Benzinga Newsdesk
Monday, December 02, 2024
UroGen Announces New Data Presentations Highl...
Benzinga Newsdesk
Tuesday, November 26, 2024
UroGen Pharma Presents New Data From A Long-T...
Benzinga Newsdesk
Wednesday, November 06, 2024
EF Hutton Maintains Buy on UroGen Pharma, Mai...
Benzinga Newsdesk
UroGen Pharma Expects Full-year 2024 JELMYTO ...
Benzinga Newsdesk
UroGen Pharma Q3 2024 GAAP EPS $(0.55) Beats ...
Benzinga Newsdesk
Tuesday, October 29, 2024
EF Hutton Maintains Buy on UroGen Pharma, Mai...
Benzinga Newsdesk
Monday, October 28, 2024
UroGen Highlights Publication Of Phase 3 ENVI...
Benzinga Newsdesk
Monday, October 21, 2024
EF Hutton Maintains Buy on UroGen Pharma, Mai...
Benzinga Newsdesk
Wednesday, October 16, 2024
EF Hutton Maintains Buy on UroGen Pharma, Mai...
Benzinga Newsdesk
Oppenheimer Reiterates Outperform on UroGen P...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on UroGen P...
Benzinga Newsdesk
Tuesday, October 15, 2024
UroGen Pharma shares are trading higher after...
Benzinga Newsdesk
UroGen Announces FDA Acceptance Of Its New Dr...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on UroGen ...
Benzinga Newsdesk
Monday, October 14, 2024
EF Hutton Initiates Coverage On UroGen Pharma...
Benzinga Newsdesk
Wednesday, October 09, 2024
UroGen Pharma Appoints Chris Degnan As Chief ...
Benzinga Newsdesk
Thursday, October 03, 2024
HC Wainwright & Co. Reiterates Buy on UroGen ...
Benzinga Newsdesk
Wednesday, October 02, 2024
UroGen Pharma Doses First Patient In Phase 3 ...
Benzinga Newsdesk
Monday, September 16, 2024
UroGen Receives New U.S. Patent Allowance For...
Benzinga Newsdesk
Thursday, August 22, 2024
Guggenheim Initiates Coverage On UroGen Pharm...
Benzinga Newsdesk
Thursday, August 15, 2024
HC Wainwright & Co. Reiterates Buy on UroGen ...
Benzinga Newsdesk
Wednesday, August 14, 2024
UroGen Submits Completed UGN-102 NDA Seeking ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on UroGen ...
Benzinga Newsdesk
Tuesday, August 13, 2024
UroGen Pharma Says The Latest DOR Data Is Exp...
Benzinga Newsdesk
UroGen Pharma Ended Q2 2024 With $241.3M In C...
Benzinga Newsdesk
UroGen Pharma Q2 2024 GAAP EPS $(0.91) Misses...
Benzinga Newsdesk
Monday, July 01, 2024
HC Wainwright & Co. Reiterates Buy on UroGen ...
Benzinga Newsdesk
Tuesday, June 18, 2024
NextEra Energy, Lennar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Avi Kapoor
On Monday, UroGen Pharma Priced The Public Of...
Benzinga Newsdesk
Monday, June 17, 2024
UroGen Pharma Announces Public Offering Of Or...
Benzinga Newsdesk
Urogen Pharma Surges 9.7%: Is This an Indication of Further Gains?
Zacks
Friday, June 14, 2024
Ladenburg Thalmann Maintains Buy on UroGen Ph...
Benzinga Newsdesk
UroGen Pharma shares are trading higher after...
Benzinga Newsdesk
Hasbro, Tutor Perini, Arm Holdings And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Oppenheimer Maintains Outperform on UroGen Ph...
Benzinga Newsdesk
Hasbro To Rally Around 38%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on UroGen P...
Benzinga Newsdesk
Thursday, June 13, 2024
UroGen Pharma shares are trading higher after...
Benzinga Newsdesk
UroGen Pharma Shares Resume Trade
Benzinga Newsdesk
Trading Halt: Halt status updated at 11:10:00...
Benzinga Newsdesk
UroGen Pharma Announces 82.3% 12-Month Durati...
Benzinga Newsdesk
Trading Halt: Halted at 10:40:00 a.m. ET - Tr...
Benzinga Newsdesk
Tuesday, May 14, 2024
Oppenheimer Maintains Outperform on UroGen Ph...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on UroGen ...
Benzinga Newsdesk
Monday, May 13, 2024
UroGen Pharma Announces Date For ENVISION Dat...
Benzinga Newsdesk
UroGen Pharma Q1 EPS $(0.97) Misses $(0.87) E...
Benzinga Newsdesk
Monday, May 06, 2024
HC Wainwright & Co. Reiterates Buy on UroGen ...
Benzinga Newsdesk
Show More